EFM
IRON icon

E Fund Management’s Disc Medicine IRON Stock Holding History

E Fund Management’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$274K Sell
3,746
-3,026
-45% -$208K 0.01% 401
2026
Q1 		$433K Buy
+6,772
New +$470K 0.01% 314
2024
Q2 		– Sell
-4,861
Closed -$303K – 342
2024
Q1 		$303K Buy
+4,861
New +$315K 0.02% 275

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

E Fund Management's IRON Position: Q2 2026 in Review

E Fund Management reduced its Disc Medicine (IRON) stake by 45% in Q2 2026, selling an estimated $208K and leaving 3,746 shares worth $274K. The position accounts for 0.01% of the portfolio, ranked #401.

E Fund Management first reported a position in IRON in Q1 2024 and has held it in 3 quarters since. The position peaked at $433K in Q1 2026. 215 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • E Fund Management held 3,746 shares of Disc Medicine worth $274K as of Q2 2026.
  • E Fund Management sold 3,026 Disc Medicine shares in Q2 2026, an estimated $208K.
  • Disc Medicine made up 0.01% of E Fund Management's portfolio in Q2 2026, its #401 holding.
  • E Fund Management first reported a position in Disc Medicine in Q1 2024 and has held it in 3 quarters since.
  • E Fund Management's Disc Medicine position peaked at $433K in Q1 2026.
  • 215 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.